Our body’s immune system is meant to protect the body from harmful invaders, like pathogens, bacteria, toxins, etc. However, various genetic factors, smoking, infections, hormonal changes, and immune system abnormalities cause the immune system to become overactive. As a result, it mistakenly starts to attack the body’s healthy cells and leads to autoimmune disorders, like rheumatoid arthritis (RA). Unlike osteoarthritis, RA primarily affects the lining of the joints, known as the synovial membrane. As a result, it leads to: Chronic inflammation Thickening of the synovial lining Damage to the cartilage and bone Over time, the inflammation leads to joint deformity, loss of function, and disability if not managed properly. While there is no permanent cure, modern therapies can slow or stop joint damage and help patients live their lives easily. That is why early detection and proper treatment are the key to treating RA. Here is where the thromboxane A2 (TXA2) ELISA kit comes into play. What is the Thromboxane A2 (TXA2) ELISA Kit? In order to understand the mechanism of RA and develop targeted therapies, researchers rely on biochemical markers that affect the u...